
Biotechnology • Pharmaceuticals • Healthcare Insurance
Apellis Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic treatments targeting the complement system. The company is dedicated to transforming the treatment landscape for debilitating diseases, with a particular focus on ophthalmology and rare diseases. Apellis is committed to advancing complement science to address unmet medical needs through its robust pipeline of clinical trials and approved products. With a keen emphasis on patient-centered approaches and community engagement, Apellis strives to deliver breakthrough therapies to improve patient outcomes.
October 29
Sr. Director of Clinical Science at Apellis, leading clinical programs and multidisciplinary teams for innovative biopharmaceutical therapies. Overseeing clinical strategy and execution in a remote setting.